Business · 16.10.2026

Sobi receives positive CHMP opinion for TRYNGOLZA® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Sobi has received a positive opinion from the CHMP for its treatment TRYNGOLZA® (olezarsen) for severe hypertriglyceridemia, based on Phase 3 CORE and CORE2 results.